nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—TNF—malaria	0.312	1	CbGaD
Thalidomide—CYP2E1—Sulfadiazine—malaria	0.0358	0.0804	CbGbCtD
Thalidomide—CYP2E1—Proguanil—malaria	0.0286	0.0642	CbGbCtD
Thalidomide—CYP1A1—Quinine—malaria	0.0239	0.0536	CbGbCtD
Thalidomide—CYP3A5—Artemether—malaria	0.0237	0.0531	CbGbCtD
Thalidomide—PTGS2—Dapsone—malaria	0.0214	0.0481	CbGbCtD
Thalidomide—CYP1A1—Quinidine—malaria	0.021	0.0471	CbGbCtD
Thalidomide—CYP2C19—Artemether—malaria	0.0191	0.0428	CbGbCtD
Thalidomide—CYP2C9—Sulfadiazine—malaria	0.0187	0.0419	CbGbCtD
Thalidomide—CYP2C9—Pyrimethamine—malaria	0.0187	0.0419	CbGbCtD
Thalidomide—CYP2E1—Quinine—malaria	0.0184	0.0414	CbGbCtD
Thalidomide—PTGS1—Dapsone—malaria	0.0181	0.0406	CbGbCtD
Thalidomide—CYP2C19—Proguanil—malaria	0.0179	0.0403	CbGbCtD
Thalidomide—CYP1A2—Proguanil—malaria	0.0166	0.0372	CbGbCtD
Thalidomide—CYP2E1—Quinidine—malaria	0.0162	0.0364	CbGbCtD
Thalidomide—CYP2C9—Artemether—malaria	0.0159	0.0356	CbGbCtD
Thalidomide—CYP2C9—Proguanil—malaria	0.0149	0.0335	CbGbCtD
Thalidomide—CYP3A5—Quinine—malaria	0.0143	0.0322	CbGbCtD
Thalidomide—CYP2E1—Dapsone—malaria	0.014	0.0314	CbGbCtD
Thalidomide—CYP1A2—Pentoxifylline—malaria	0.0119	0.0267	CbGbCtD
Thalidomide—CYP2C19—Quinine—malaria	0.0116	0.0259	CbGbCtD
Thalidomide—CYP3A5—Dapsone—malaria	0.0109	0.0244	CbGbCtD
Thalidomide—CYP1A2—Quinine—malaria	0.0107	0.0239	CbGbCtD
Thalidomide—CYP2C9—Quinine—malaria	0.00961	0.0216	CbGbCtD
Thalidomide—CYP1A2—Quinidine—malaria	0.00937	0.021	CbGbCtD
Thalidomide—CYP2C19—Dapsone—malaria	0.00876	0.0197	CbGbCtD
Thalidomide—CYP2C9—Quinidine—malaria	0.00845	0.019	CbGbCtD
Thalidomide—CYP2C9—Dapsone—malaria	0.00728	0.0164	CbGbCtD
Thalidomide—TNF—blood—malaria	0.00212	0.0432	CbGeAlD
Thalidomide—Pomalidomide—TNF—malaria	0.00203	1	CrCbGaD
Thalidomide—NFKB1—saliva-secreting gland—malaria	0.00191	0.039	CbGeAlD
Thalidomide—NFKB1—hematopoietic system—malaria	0.00182	0.0372	CbGeAlD
Thalidomide—CRBN—saliva-secreting gland—malaria	0.0016	0.0327	CbGeAlD
Thalidomide—CRBN—hematopoietic system—malaria	0.00153	0.0312	CbGeAlD
Thalidomide—NFKB1—kidney—malaria	0.00149	0.0305	CbGeAlD
Thalidomide—FGFR2—saliva-secreting gland—malaria	0.00143	0.0293	CbGeAlD
Thalidomide—FGFR2—hematopoietic system—malaria	0.00137	0.0279	CbGeAlD
Thalidomide—NFKB1—digestive system—malaria	0.00127	0.0259	CbGeAlD
Thalidomide—NFKB1—blood—malaria	0.00121	0.0246	CbGeAlD
Thalidomide—NFKB1—bone marrow—malaria	0.00117	0.0238	CbGeAlD
Thalidomide—FGFR2—kidney—malaria	0.00112	0.0229	CbGeAlD
Thalidomide—CYP2C19—blood plasma—malaria	0.00111	0.0227	CbGeAlD
Thalidomide—CRBN—digestive system—malaria	0.00106	0.0217	CbGeAlD
Thalidomide—CRBN—blood—malaria	0.00101	0.0207	CbGeAlD
Thalidomide—CRBN—bone marrow—malaria	0.000979	0.02	CbGeAlD
Thalidomide—FGFR2—digestive system—malaria	0.000951	0.0194	CbGeAlD
Thalidomide—NFKB1—liver—malaria	0.000943	0.0193	CbGeAlD
Thalidomide—CYP1A2—blood plasma—malaria	0.000907	0.0185	CbGeAlD
Thalidomide—FGFR2—blood—malaria	0.000906	0.0185	CbGeAlD
Thalidomide—PTGS1—endothelium—malaria	0.000885	0.0181	CbGeAlD
Thalidomide—CYP3A5—blood plasma—malaria	0.000875	0.0179	CbGeAlD
Thalidomide—CYP2C9—blood plasma—malaria	0.000861	0.0176	CbGeAlD
Thalidomide—PTGS2—endothelium—malaria	0.000846	0.0173	CbGeAlD
Thalidomide—CYP2E1—blood plasma—malaria	0.000816	0.0167	CbGeAlD
Thalidomide—CRBN—liver—malaria	0.000791	0.0162	CbGeAlD
Thalidomide—PTGS1—blood plasma—malaria	0.000786	0.0161	CbGeAlD
Thalidomide—PTGS2—blood plasma—malaria	0.000752	0.0154	CbGeAlD
Thalidomide—NFKB1—brain—malaria	0.000749	0.0153	CbGeAlD
Thalidomide—FGFR2—liver—malaria	0.000709	0.0145	CbGeAlD
Thalidomide—CRBN—brain—malaria	0.000627	0.0128	CbGeAlD
Thalidomide—CYP2C19—hematopoietic system—malaria	0.000614	0.0126	CbGeAlD
Thalidomide—FGFR2—brain—malaria	0.000562	0.0115	CbGeAlD
Thalidomide—CYP1A2—hematopoietic system—malaria	0.000502	0.0103	CbGeAlD
Thalidomide—CYP1A1—hematopoietic system—malaria	0.000495	0.0101	CbGeAlD
Thalidomide—CYP3A5—hematopoietic system—malaria	0.000484	0.00989	CbGeAlD
Thalidomide—CYP2C9—hematopoietic system—malaria	0.000476	0.00973	CbGeAlD
Thalidomide—CYP2E1—hematopoietic system—malaria	0.000451	0.00922	CbGeAlD
Thalidomide—PTGS1—hematopoietic system—malaria	0.000435	0.00888	CbGeAlD
Thalidomide—CYP2C19—digestive system—malaria	0.000427	0.00873	CbGeAlD
Thalidomide—PTGS2—hematopoietic system—malaria	0.000416	0.00849	CbGeAlD
Thalidomide—CYP2C19—blood—malaria	0.000407	0.00832	CbGeAlD
Thalidomide—CYP1A1—kidney—malaria	0.000406	0.00829	CbGeAlD
Thalidomide—CYP3A5—kidney—malaria	0.000397	0.0081	CbGeAlD
Thalidomide—CYP2E1—kidney—malaria	0.00037	0.00756	CbGeAlD
Thalidomide—PTGS1—kidney—malaria	0.000356	0.00728	CbGeAlD
Thalidomide—CYP1A2—digestive system—malaria	0.000349	0.00713	CbGeAlD
Thalidomide—CYP1A1—digestive system—malaria	0.000344	0.00703	CbGeAlD
Thalidomide—PTGS2—kidney—malaria	0.000341	0.00696	CbGeAlD
Thalidomide—CYP3A5—digestive system—malaria	0.000337	0.00688	CbGeAlD
Thalidomide—CYP1A2—blood—malaria	0.000332	0.00679	CbGeAlD
Thalidomide—CYP2C9—digestive system—malaria	0.000331	0.00677	CbGeAlD
Thalidomide—CYP1A1—blood—malaria	0.000328	0.0067	CbGeAlD
Thalidomide—CYP3A5—blood—malaria	0.000321	0.00655	CbGeAlD
Thalidomide—CYP2C19—liver—malaria	0.000318	0.0065	CbGeAlD
Thalidomide—CYP2C9—blood—malaria	0.000316	0.00645	CbGeAlD
Thalidomide—CYP2E1—digestive system—malaria	0.000314	0.00641	CbGeAlD
Thalidomide—PTGS1—digestive system—malaria	0.000302	0.00618	CbGeAlD
Thalidomide—CYP2E1—blood—malaria	0.000299	0.00611	CbGeAlD
Thalidomide—PTGS2—digestive system—malaria	0.000289	0.0059	CbGeAlD
Thalidomide—PTGS1—blood—malaria	0.000288	0.00589	CbGeAlD
Thalidomide—PTGS2—blood—malaria	0.000275	0.00563	CbGeAlD
Thalidomide—PTGS2—bone marrow—malaria	0.000266	0.00544	CbGeAlD
Thalidomide—CYP1A2—liver—malaria	0.00026	0.00531	CbGeAlD
Thalidomide—CYP1A1—liver—malaria	0.000256	0.00524	CbGeAlD
Thalidomide—CYP3A5—liver—malaria	0.000251	0.00512	CbGeAlD
Thalidomide—CYP2C9—liver—malaria	0.000247	0.00504	CbGeAlD
Thalidomide—CYP2E1—liver—malaria	0.000234	0.00478	CbGeAlD
Thalidomide—PTGS2—liver—malaria	0.000215	0.0044	CbGeAlD
Thalidomide—CYP1A1—brain—malaria	0.000203	0.00416	CbGeAlD
Thalidomide—CYP2E1—brain—malaria	0.000186	0.00379	CbGeAlD
Thalidomide—PTGS1—brain—malaria	0.000179	0.00365	CbGeAlD
Thalidomide—PTGS2—brain—malaria	0.000171	0.00349	CbGeAlD
Thalidomide—Muscle spasms—Clindamycin—malaria	0.000146	0.00122	CcSEcCtD
Thalidomide—Decreased appetite—Sulfadiazine—malaria	0.000145	0.0012	CcSEcCtD
Thalidomide—Eye disorder—Quinidine barbiturate—malaria	0.000144	0.0012	CcSEcCtD
Thalidomide—Tinnitus—Quinidine barbiturate—malaria	0.000144	0.0012	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Sulfadiazine—malaria	0.000144	0.0012	CcSEcCtD
Thalidomide—Cardiac disorder—Quinidine barbiturate—malaria	0.000143	0.00119	CcSEcCtD
Thalidomide—Vertigo—Dapsone—malaria	0.000141	0.00117	CcSEcCtD
Thalidomide—Vision blurred—Quinidine—malaria	0.000141	0.00117	CcSEcCtD
Thalidomide—Vision blurred—Quinine—malaria	0.000141	0.00117	CcSEcCtD
Thalidomide—Anaemia—Clindamycin—malaria	0.00014	0.00117	CcSEcCtD
Thalidomide—Tremor—Quinine—malaria	0.00014	0.00116	CcSEcCtD
Thalidomide—Tremor—Quinidine—malaria	0.00014	0.00116	CcSEcCtD
Thalidomide—Immune system disorder—Quinidine barbiturate—malaria	0.00014	0.00116	CcSEcCtD
Thalidomide—Immune system disorder—Pentoxifylline—malaria	0.000139	0.00116	CcSEcCtD
Thalidomide—Mediastinal disorder—Quinidine barbiturate—malaria	0.000139	0.00116	CcSEcCtD
Thalidomide—Chills—Quinidine barbiturate—malaria	0.000139	0.00115	CcSEcCtD
Thalidomide—Arrhythmia—Pentoxifylline—malaria	0.000138	0.00115	CcSEcCtD
Thalidomide—Cough—Dapsone—malaria	0.000137	0.00114	CcSEcCtD
Thalidomide—Agitation—Quinine—malaria	0.000137	0.00114	CcSEcCtD
Thalidomide—Agitation—Quinidine—malaria	0.000137	0.00114	CcSEcCtD
Thalidomide—Vertigo—Clindamycin—malaria	0.000137	0.00114	CcSEcCtD
Thalidomide—Angioedema—Quinine—malaria	0.000136	0.00113	CcSEcCtD
Thalidomide—Angioedema—Quinidine—malaria	0.000136	0.00113	CcSEcCtD
Thalidomide—Gastrointestinal pain—Sulfadiazine—malaria	0.000136	0.00113	CcSEcCtD
Thalidomide—Leukopenia—Clindamycin—malaria	0.000136	0.00113	CcSEcCtD
Thalidomide—Mental disorder—Quinidine barbiturate—malaria	0.000135	0.00113	CcSEcCtD
Thalidomide—Malnutrition—Quinidine barbiturate—malaria	0.000135	0.00112	CcSEcCtD
Thalidomide—Vertigo—Quinidine—malaria	0.000134	0.00111	CcSEcCtD
Thalidomide—Vertigo—Quinine—malaria	0.000134	0.00111	CcSEcCtD
Thalidomide—Syncope—Quinidine—malaria	0.000134	0.00111	CcSEcCtD
Thalidomide—Syncope—Quinine—malaria	0.000134	0.00111	CcSEcCtD
Thalidomide—Leukopenia—Quinine—malaria	0.000133	0.00111	CcSEcCtD
Thalidomide—Leukopenia—Quinidine—malaria	0.000133	0.00111	CcSEcCtD
Thalidomide—Flatulence—Pentoxifylline—malaria	0.000132	0.0011	CcSEcCtD
Thalidomide—Urticaria—Sulfadiazine—malaria	0.000132	0.0011	CcSEcCtD
Thalidomide—Tension—Quinidine barbiturate—malaria	0.000132	0.0011	CcSEcCtD
Thalidomide—Tension—Pentoxifylline—malaria	0.000132	0.0011	CcSEcCtD
Thalidomide—Palpitations—Quinine—malaria	0.000132	0.0011	CcSEcCtD
Thalidomide—Palpitations—Quinidine—malaria	0.000132	0.0011	CcSEcCtD
Thalidomide—Abdominal pain—Sulfadiazine—malaria	0.000132	0.0011	CcSEcCtD
Thalidomide—Body temperature increased—Sulfadiazine—malaria	0.000132	0.0011	CcSEcCtD
Thalidomide—Dysgeusia—Pentoxifylline—malaria	0.000132	0.00109	CcSEcCtD
Thalidomide—Hypertension—Clindamycin—malaria	0.000131	0.00109	CcSEcCtD
Thalidomide—Loss of consciousness—Quinine—malaria	0.000131	0.00109	CcSEcCtD
Thalidomide—Loss of consciousness—Quinidine—malaria	0.000131	0.00109	CcSEcCtD
Thalidomide—Nervousness—Quinidine barbiturate—malaria	0.000131	0.00109	CcSEcCtD
Thalidomide—Nervousness—Pentoxifylline—malaria	0.00013	0.00109	CcSEcCtD
Thalidomide—Back pain—Pentoxifylline—malaria	0.00013	0.00108	CcSEcCtD
Thalidomide—Convulsion—Quinidine—malaria	0.000129	0.00107	CcSEcCtD
Thalidomide—Convulsion—Quinine—malaria	0.000129	0.00107	CcSEcCtD
Thalidomide—Muscle spasms—Pentoxifylline—malaria	0.000129	0.00107	CcSEcCtD
Thalidomide—Discomfort—Clindamycin—malaria	0.000128	0.00106	CcSEcCtD
Thalidomide—Myalgia—Quinine—malaria	0.000127	0.00106	CcSEcCtD
Thalidomide—Myalgia—Quinidine—malaria	0.000127	0.00106	CcSEcCtD
Thalidomide—Chest pain—Quinine—malaria	0.000127	0.00106	CcSEcCtD
Thalidomide—Chest pain—Quinidine—malaria	0.000127	0.00106	CcSEcCtD
Thalidomide—Vision blurred—Quinidine barbiturate—malaria	0.000127	0.00105	CcSEcCtD
Thalidomide—Vision blurred—Pentoxifylline—malaria	0.000127	0.00105	CcSEcCtD
Thalidomide—Tremor—Quinidine barbiturate—malaria	0.000126	0.00105	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000126	0.00105	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000126	0.00105	CcSEcCtD
Thalidomide—Tremor—Pentoxifylline—malaria	0.000126	0.00105	CcSEcCtD
Thalidomide—Tachycardia—Dapsone—malaria	0.000125	0.00104	CcSEcCtD
Thalidomide—Ill-defined disorder—Pentoxifylline—malaria	0.000125	0.00104	CcSEcCtD
Thalidomide—Anaemia—Pentoxifylline—malaria	0.000124	0.00103	CcSEcCtD
Thalidomide—Agitation—Quinidine barbiturate—malaria	0.000124	0.00103	CcSEcCtD
Thalidomide—Agitation—Pentoxifylline—malaria	0.000123	0.00103	CcSEcCtD
Thalidomide—Angioedema—Quinidine barbiturate—malaria	0.000123	0.00102	CcSEcCtD
Thalidomide—Angioedema—Pentoxifylline—malaria	0.000123	0.00102	CcSEcCtD
Thalidomide—Hypersensitivity—Sulfadiazine—malaria	0.000123	0.00102	CcSEcCtD
Thalidomide—Confusional state—Quinine—malaria	0.000123	0.00102	CcSEcCtD
Thalidomide—Confusional state—Quinidine—malaria	0.000123	0.00102	CcSEcCtD
Thalidomide—Oedema—Quinidine—malaria	0.000122	0.00101	CcSEcCtD
Thalidomide—Oedema—Quinine—malaria	0.000122	0.00101	CcSEcCtD
Thalidomide—Thrombocytopenia—Clindamycin—malaria	0.000121	0.00101	CcSEcCtD
Thalidomide—Malaise—Pentoxifylline—malaria	0.000121	0.00101	CcSEcCtD
Thalidomide—Vertigo—Quinidine barbiturate—malaria	0.000121	0.00101	CcSEcCtD
Thalidomide—Syncope—Quinidine barbiturate—malaria	0.000121	0.001	CcSEcCtD
Thalidomide—Leukopenia—Quinidine barbiturate—malaria	0.00012	0.001	CcSEcCtD
Thalidomide—Leukopenia—Pentoxifylline—malaria	0.00012	0.001	CcSEcCtD
Thalidomide—Shock—Quinidine—malaria	0.00012	0.000996	CcSEcCtD
Thalidomide—Shock—Quinine—malaria	0.00012	0.000996	CcSEcCtD
Thalidomide—Nervous system disorder—Quinidine—malaria	0.000119	0.000993	CcSEcCtD
Thalidomide—Nervous system disorder—Quinine—malaria	0.000119	0.000993	CcSEcCtD
Thalidomide—Thrombocytopenia—Quinidine—malaria	0.000119	0.000991	CcSEcCtD
Thalidomide—Thrombocytopenia—Quinine—malaria	0.000119	0.000991	CcSEcCtD
Thalidomide—Palpitations—Quinidine barbiturate—malaria	0.000119	0.000989	CcSEcCtD
Thalidomide—Tachycardia—Quinine—malaria	0.000119	0.000988	CcSEcCtD
Thalidomide—Tachycardia—Quinidine—malaria	0.000119	0.000988	CcSEcCtD
Thalidomide—Palpitations—Pentoxifylline—malaria	0.000119	0.000987	CcSEcCtD
Thalidomide—Loss of consciousness—Quinidine barbiturate—malaria	0.000118	0.000984	CcSEcCtD
Thalidomide—Skin disorder—Quinine—malaria	0.000118	0.000983	CcSEcCtD
Thalidomide—Skin disorder—Quinidine—malaria	0.000118	0.000983	CcSEcCtD
Thalidomide—Pruritus—Sulfadiazine—malaria	0.000118	0.00098	CcSEcCtD
Thalidomide—Hyperhidrosis—Quinine—malaria	0.000118	0.000979	CcSEcCtD
Thalidomide—Hyperhidrosis—Quinidine—malaria	0.000118	0.000979	CcSEcCtD
Thalidomide—Convulsion—Quinidine barbiturate—malaria	0.000117	0.00097	CcSEcCtD
Thalidomide—Convulsion—Pentoxifylline—malaria	0.000116	0.000968	CcSEcCtD
Thalidomide—Anorexia—Quinine—malaria	0.000116	0.000965	CcSEcCtD
Thalidomide—Anorexia—Quinidine—malaria	0.000116	0.000965	CcSEcCtD
Thalidomide—Insomnia—Dapsone—malaria	0.000116	0.000965	CcSEcCtD
Thalidomide—Hypertension—Pentoxifylline—malaria	0.000116	0.000965	CcSEcCtD
Thalidomide—Hypotension—Clindamycin—malaria	0.000116	0.000964	CcSEcCtD
Thalidomide—Chest pain—Quinidine barbiturate—malaria	0.000115	0.000953	CcSEcCtD
Thalidomide—Arthralgia—Quinidine barbiturate—malaria	0.000115	0.000953	CcSEcCtD
Thalidomide—Myalgia—Quinidine barbiturate—malaria	0.000115	0.000953	CcSEcCtD
Thalidomide—Chest pain—Pentoxifylline—malaria	0.000114	0.000951	CcSEcCtD
Thalidomide—Myalgia—Pentoxifylline—malaria	0.000114	0.000951	CcSEcCtD
Thalidomide—Anxiety—Quinidine barbiturate—malaria	0.000114	0.00095	CcSEcCtD
Thalidomide—Diarrhoea—Sulfadiazine—malaria	0.000114	0.000948	CcSEcCtD
Thalidomide—Anxiety—Pentoxifylline—malaria	0.000114	0.000948	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000114	0.000946	CcSEcCtD
Thalidomide—Hypotension—Quinidine—malaria	0.000114	0.000946	CcSEcCtD
Thalidomide—Hypotension—Quinine—malaria	0.000114	0.000946	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000114	0.000945	CcSEcCtD
Thalidomide—Discomfort—Pentoxifylline—malaria	0.000113	0.00094	CcSEcCtD
Thalidomide—Dry mouth—Pentoxifylline—malaria	0.000112	0.00093	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Quinine—malaria	0.000111	0.000922	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Quinidine—malaria	0.000111	0.000922	CcSEcCtD
Thalidomide—Confusional state—Quinidine barbiturate—malaria	0.000111	0.000921	CcSEcCtD
Thalidomide—Dyspnoea—Clindamycin—malaria	0.000111	0.00092	CcSEcCtD
Thalidomide—Confusional state—Pentoxifylline—malaria	0.000111	0.000919	CcSEcCtD
Thalidomide—Oedema—Quinidine barbiturate—malaria	0.00011	0.000913	CcSEcCtD
Thalidomide—Oedema—Pentoxifylline—malaria	0.00011	0.000912	CcSEcCtD
Thalidomide—Dyspepsia—Clindamycin—malaria	0.000109	0.000908	CcSEcCtD
Thalidomide—Infection—Pentoxifylline—malaria	0.000109	0.000906	CcSEcCtD
Thalidomide—Dyspnoea—Quinine—malaria	0.000108	0.000902	CcSEcCtD
Thalidomide—Dyspnoea—Quinidine—malaria	0.000108	0.000902	CcSEcCtD
Thalidomide—Shock—Quinidine barbiturate—malaria	0.000108	0.000899	CcSEcCtD
Thalidomide—Shock—Pentoxifylline—malaria	0.000108	0.000897	CcSEcCtD
Thalidomide—Nervous system disorder—Quinidine barbiturate—malaria	0.000108	0.000896	CcSEcCtD
Thalidomide—Thrombocytopenia—Quinidine barbiturate—malaria	0.000108	0.000894	CcSEcCtD
Thalidomide—Thrombocytopenia—Pentoxifylline—malaria	0.000107	0.000893	CcSEcCtD
Thalidomide—Tachycardia—Quinidine barbiturate—malaria	0.000107	0.000892	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Clindamycin—malaria	0.000107	0.000891	CcSEcCtD
Thalidomide—Tachycardia—Pentoxifylline—malaria	0.000107	0.00089	CcSEcCtD
Thalidomide—Fatigue—Clindamycin—malaria	0.000107	0.00089	CcSEcCtD
Thalidomide—Skin disorder—Quinidine barbiturate—malaria	0.000107	0.000887	CcSEcCtD
Thalidomide—Skin disorder—Pentoxifylline—malaria	0.000106	0.000886	CcSEcCtD
Thalidomide—Hyperhidrosis—Quinidine barbiturate—malaria	0.000106	0.000883	CcSEcCtD
Thalidomide—Constipation—Clindamycin—malaria	0.000106	0.000882	CcSEcCtD
Thalidomide—Pain—Clindamycin—malaria	0.000106	0.000882	CcSEcCtD
Thalidomide—Hyperhidrosis—Pentoxifylline—malaria	0.000106	0.000881	CcSEcCtD
Thalidomide—Vomiting—Sulfadiazine—malaria	0.000106	0.000881	CcSEcCtD
Thalidomide—Decreased appetite—Quinidine—malaria	0.000106	0.00088	CcSEcCtD
Thalidomide—Decreased appetite—Quinine—malaria	0.000106	0.00088	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Quinidine—malaria	0.000105	0.000874	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Quinine—malaria	0.000105	0.000874	CcSEcCtD
Thalidomide—Rash—Sulfadiazine—malaria	0.000105	0.000874	CcSEcCtD
Thalidomide—Dermatitis—Sulfadiazine—malaria	0.000105	0.000873	CcSEcCtD
Thalidomide—Gastrointestinal pain—Dapsone—malaria	0.000105	0.000872	CcSEcCtD
Thalidomide—Anorexia—Quinidine barbiturate—malaria	0.000105	0.000871	CcSEcCtD
Thalidomide—Anorexia—Pentoxifylline—malaria	0.000104	0.000869	CcSEcCtD
Thalidomide—Headache—Sulfadiazine—malaria	0.000104	0.000868	CcSEcCtD
Thalidomide—Hypotension—Quinidine barbiturate—malaria	0.000103	0.000854	CcSEcCtD
Thalidomide—Hypotension—Pentoxifylline—malaria	0.000102	0.000852	CcSEcCtD
Thalidomide—Gastrointestinal pain—Clindamycin—malaria	0.000101	0.000844	CcSEcCtD
Thalidomide—Body temperature increased—Dapsone—malaria	0.000101	0.000843	CcSEcCtD
Thalidomide—Abdominal pain—Dapsone—malaria	0.000101	0.000843	CcSEcCtD
Thalidomide—Feeling abnormal—Quinidine—malaria	0.0001	0.000834	CcSEcCtD
Thalidomide—Feeling abnormal—Quinine—malaria	0.0001	0.000834	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.0001	0.000832	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Pentoxifylline—malaria	9.99e-05	0.000831	CcSEcCtD
Thalidomide—Gastrointestinal pain—Quinidine—malaria	9.95e-05	0.000828	CcSEcCtD
Thalidomide—Gastrointestinal pain—Quinine—malaria	9.95e-05	0.000828	CcSEcCtD
Thalidomide—Insomnia—Pentoxifylline—malaria	9.91e-05	0.000825	CcSEcCtD
Thalidomide—Nausea—Sulfadiazine—malaria	9.89e-05	0.000823	CcSEcCtD
Thalidomide—Urticaria—Clindamycin—malaria	9.85e-05	0.00082	CcSEcCtD
Thalidomide—Body temperature increased—Clindamycin—malaria	9.8e-05	0.000816	CcSEcCtD
Thalidomide—Abdominal pain—Clindamycin—malaria	9.8e-05	0.000816	CcSEcCtD
Thalidomide—Dyspnoea—Quinidine barbiturate—malaria	9.79e-05	0.000814	CcSEcCtD
Thalidomide—Dyspnoea—Pentoxifylline—malaria	9.77e-05	0.000813	CcSEcCtD
Thalidomide—Somnolence—Quinidine barbiturate—malaria	9.76e-05	0.000812	CcSEcCtD
Thalidomide—Somnolence—Pentoxifylline—malaria	9.74e-05	0.000811	CcSEcCtD
Thalidomide—Urticaria—Quinine—malaria	9.67e-05	0.000804	CcSEcCtD
Thalidomide—Urticaria—Quinidine—malaria	9.67e-05	0.000804	CcSEcCtD
Thalidomide—Dyspepsia—Pentoxifylline—malaria	9.65e-05	0.000803	CcSEcCtD
Thalidomide—Body temperature increased—Quinidine—malaria	9.62e-05	0.0008	CcSEcCtD
Thalidomide—Abdominal pain—Quinine—malaria	9.62e-05	0.0008	CcSEcCtD
Thalidomide—Abdominal pain—Quinidine—malaria	9.62e-05	0.0008	CcSEcCtD
Thalidomide—Body temperature increased—Quinine—malaria	9.62e-05	0.0008	CcSEcCtD
Thalidomide—Decreased appetite—Quinidine barbiturate—malaria	9.55e-05	0.000794	CcSEcCtD
Thalidomide—Decreased appetite—Pentoxifylline—malaria	9.53e-05	0.000793	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Quinidine barbiturate—malaria	9.48e-05	0.000789	CcSEcCtD
Thalidomide—Pain—Quinidine barbiturate—malaria	9.39e-05	0.000781	CcSEcCtD
Thalidomide—Constipation—Quinidine barbiturate—malaria	9.39e-05	0.000781	CcSEcCtD
Thalidomide—Constipation—Pentoxifylline—malaria	9.37e-05	0.00078	CcSEcCtD
Thalidomide—Hypersensitivity—Clindamycin—malaria	9.14e-05	0.00076	CcSEcCtD
Thalidomide—Feeling abnormal—Quinidine barbiturate—malaria	9.05e-05	0.000753	CcSEcCtD
Thalidomide—Feeling abnormal—Pentoxifylline—malaria	9.03e-05	0.000751	CcSEcCtD
Thalidomide—Gastrointestinal pain—Quinidine barbiturate—malaria	8.98e-05	0.000747	CcSEcCtD
Thalidomide—Hypersensitivity—Quinidine—malaria	8.96e-05	0.000746	CcSEcCtD
Thalidomide—Hypersensitivity—Quinine—malaria	8.96e-05	0.000746	CcSEcCtD
Thalidomide—Gastrointestinal pain—Pentoxifylline—malaria	8.96e-05	0.000746	CcSEcCtD
Thalidomide—Asthenia—Clindamycin—malaria	8.9e-05	0.00074	CcSEcCtD
Thalidomide—Pruritus—Clindamycin—malaria	8.77e-05	0.00073	CcSEcCtD
Thalidomide—Asthenia—Quinine—malaria	8.73e-05	0.000726	CcSEcCtD
Thalidomide—Asthenia—Quinidine—malaria	8.73e-05	0.000726	CcSEcCtD
Thalidomide—Urticaria—Quinidine barbiturate—malaria	8.72e-05	0.000726	CcSEcCtD
Thalidomide—Urticaria—Pentoxifylline—malaria	8.71e-05	0.000724	CcSEcCtD
Thalidomide—Body temperature increased—Quinidine barbiturate—malaria	8.68e-05	0.000722	CcSEcCtD
Thalidomide—Abdominal pain—Quinidine barbiturate—malaria	8.68e-05	0.000722	CcSEcCtD
Thalidomide—Abdominal pain—Pentoxifylline—malaria	8.66e-05	0.000721	CcSEcCtD
Thalidomide—Body temperature increased—Pentoxifylline—malaria	8.66e-05	0.000721	CcSEcCtD
Thalidomide—Pruritus—Quinidine—malaria	8.61e-05	0.000716	CcSEcCtD
Thalidomide—Pruritus—Quinine—malaria	8.61e-05	0.000716	CcSEcCtD
Thalidomide—Diarrhoea—Clindamycin—malaria	8.49e-05	0.000706	CcSEcCtD
Thalidomide—Diarrhoea—Quinidine—malaria	8.32e-05	0.000693	CcSEcCtD
Thalidomide—Diarrhoea—Quinine—malaria	8.32e-05	0.000693	CcSEcCtD
Thalidomide—Dizziness—Clindamycin—malaria	8.2e-05	0.000682	CcSEcCtD
Thalidomide—Vomiting—Dapsone—malaria	8.15e-05	0.000678	CcSEcCtD
Thalidomide—Hypersensitivity—Quinidine barbiturate—malaria	8.09e-05	0.000673	CcSEcCtD
Thalidomide—Hypersensitivity—Pentoxifylline—malaria	8.08e-05	0.000672	CcSEcCtD
Thalidomide—Dizziness—Quinidine—malaria	8.05e-05	0.000669	CcSEcCtD
Thalidomide—Dizziness—Quinine—malaria	8.05e-05	0.000669	CcSEcCtD
Thalidomide—Headache—Dapsone—malaria	8.03e-05	0.000668	CcSEcCtD
Thalidomide—Vomiting—Clindamycin—malaria	7.89e-05	0.000656	CcSEcCtD
Thalidomide—Asthenia—Quinidine barbiturate—malaria	7.88e-05	0.000655	CcSEcCtD
Thalidomide—Asthenia—Pentoxifylline—malaria	7.86e-05	0.000654	CcSEcCtD
Thalidomide—Rash—Clindamycin—malaria	7.82e-05	0.000651	CcSEcCtD
Thalidomide—Dermatitis—Clindamycin—malaria	7.81e-05	0.00065	CcSEcCtD
Thalidomide—Headache—Clindamycin—malaria	7.77e-05	0.000646	CcSEcCtD
Thalidomide—Pruritus—Quinidine barbiturate—malaria	7.77e-05	0.000646	CcSEcCtD
Thalidomide—Pruritus—Pentoxifylline—malaria	7.75e-05	0.000645	CcSEcCtD
Thalidomide—Vomiting—Quinidine—malaria	7.74e-05	0.000644	CcSEcCtD
Thalidomide—Vomiting—Quinine—malaria	7.74e-05	0.000644	CcSEcCtD
Thalidomide—Rash—Quinine—malaria	7.67e-05	0.000638	CcSEcCtD
Thalidomide—Rash—Quinidine—malaria	7.67e-05	0.000638	CcSEcCtD
Thalidomide—Dermatitis—Quinidine—malaria	7.66e-05	0.000638	CcSEcCtD
Thalidomide—Dermatitis—Quinine—malaria	7.66e-05	0.000638	CcSEcCtD
Thalidomide—Headache—Quinine—malaria	7.62e-05	0.000634	CcSEcCtD
Thalidomide—Headache—Quinidine—malaria	7.62e-05	0.000634	CcSEcCtD
Thalidomide—Nausea—Dapsone—malaria	7.62e-05	0.000634	CcSEcCtD
Thalidomide—Diarrhoea—Quinidine barbiturate—malaria	7.51e-05	0.000625	CcSEcCtD
Thalidomide—Diarrhoea—Pentoxifylline—malaria	7.5e-05	0.000624	CcSEcCtD
Thalidomide—Nausea—Clindamycin—malaria	7.37e-05	0.000613	CcSEcCtD
Thalidomide—Dizziness—Quinidine barbiturate—malaria	7.26e-05	0.000604	CcSEcCtD
Thalidomide—Dizziness—Pentoxifylline—malaria	7.25e-05	0.000603	CcSEcCtD
Thalidomide—Nausea—Quinine—malaria	7.23e-05	0.000601	CcSEcCtD
Thalidomide—Nausea—Quinidine—malaria	7.23e-05	0.000601	CcSEcCtD
Thalidomide—Vomiting—Quinidine barbiturate—malaria	6.98e-05	0.000581	CcSEcCtD
Thalidomide—Vomiting—Pentoxifylline—malaria	6.97e-05	0.00058	CcSEcCtD
Thalidomide—Rash—Quinidine barbiturate—malaria	6.92e-05	0.000576	CcSEcCtD
Thalidomide—Dermatitis—Quinidine barbiturate—malaria	6.92e-05	0.000575	CcSEcCtD
Thalidomide—Rash—Pentoxifylline—malaria	6.91e-05	0.000575	CcSEcCtD
Thalidomide—Dermatitis—Pentoxifylline—malaria	6.9e-05	0.000574	CcSEcCtD
Thalidomide—Headache—Quinidine barbiturate—malaria	6.88e-05	0.000572	CcSEcCtD
Thalidomide—Headache—Pentoxifylline—malaria	6.87e-05	0.000571	CcSEcCtD
Thalidomide—Nausea—Quinidine barbiturate—malaria	6.52e-05	0.000543	CcSEcCtD
Thalidomide—Nausea—Pentoxifylline—malaria	6.51e-05	0.000542	CcSEcCtD
Thalidomide—FGFR2—Disease—PKLR—malaria	4.45e-05	0.000624	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	4.41e-05	0.000619	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—malaria	4.41e-05	0.000619	CbGpPWpGaD
Thalidomide—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—IL6—malaria	4.39e-05	0.000617	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—malaria	4.35e-05	0.000611	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	4.34e-05	0.000609	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—TLR9—malaria	4.32e-05	0.000606	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by Interleukins—IL6—malaria	4.3e-05	0.000603	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—IL1B—malaria	4.17e-05	0.000585	CbGpPWpGaD
Thalidomide—CYP1A2—Biological oxidations—HPGDS—malaria	4.16e-05	0.000584	CbGpPWpGaD
Thalidomide—NFKB1—Activated TLR4 signalling—IL6—malaria	4.14e-05	0.000582	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—TLR9—malaria	4.1e-05	0.000575	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—IL1B—malaria	4.07e-05	0.000572	CbGpPWpGaD
Thalidomide—NFKB1—SIDS Susceptibility Pathways—TNF—malaria	3.97e-05	0.000557	CbGpPWpGaD
Thalidomide—FGFR2—Disease—G6PD—malaria	3.96e-05	0.000557	CbGpPWpGaD
Thalidomide—TNF—MAPK Signaling Pathway—IL1B—malaria	3.93e-05	0.000551	CbGpPWpGaD
Thalidomide—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—IL6—malaria	3.9e-05	0.000547	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	3.87e-05	0.000544	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—CD36—malaria	3.87e-05	0.000543	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	3.86e-05	0.000542	CbGpPWpGaD
Thalidomide—TNF—Selenium Micronutrient Network—IL6—malaria	3.86e-05	0.000541	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by Insulin receptor—IL6—malaria	3.85e-05	0.00054	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IFNG—malaria	3.84e-05	0.000539	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	3.74e-05	0.000526	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—DECR1—malaria	3.74e-05	0.000525	CbGpPWpGaD
Thalidomide—NFKB1—MAPK Signaling Pathway—TNF—malaria	3.74e-05	0.000525	CbGpPWpGaD
Thalidomide—PTGS1—Selenium Micronutrient Network—TNF—malaria	3.72e-05	0.000523	CbGpPWpGaD
Thalidomide—TNF—TNF alpha Signaling Pathway—IL6—malaria	3.72e-05	0.000522	CbGpPWpGaD
Thalidomide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	3.63e-05	0.000509	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—DHODH—malaria	3.62e-05	0.000508	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—IFNG—malaria	3.61e-05	0.000507	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.56e-05	0.000499	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CD40LG—malaria	3.52e-05	0.000493	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—IL6—malaria	3.51e-05	0.000493	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—HLA-B—malaria	3.48e-05	0.000489	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CD8A—malaria	3.48e-05	0.000488	CbGpPWpGaD
Thalidomide—NFKB1—Toll-Like Receptors Cascades—IL6—malaria	3.47e-05	0.000487	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—ACKR1—malaria	3.46e-05	0.000486	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—FCGR2A—malaria	3.45e-05	0.000484	CbGpPWpGaD
Thalidomide—TNF—Toll-like Receptor Signaling Pathway—IL6—malaria	3.43e-05	0.000481	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IL1B—malaria	3.42e-05	0.000481	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—CD36—malaria	3.41e-05	0.000479	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	3.41e-05	0.000479	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IL2—malaria	3.41e-05	0.000479	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	3.37e-05	0.000474	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—HLA-B—malaria	3.34e-05	0.000469	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—KDR—malaria	3.34e-05	0.000469	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CD40LG—malaria	3.34e-05	0.000468	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—HLA-B—malaria	3.3e-05	0.000464	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CD8A—malaria	3.3e-05	0.000463	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by SCF-KIT—IL6—malaria	3.29e-05	0.000462	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—ACKR1—malaria	3.29e-05	0.000461	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CD36—malaria	3.28e-05	0.00046	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—FCGR2A—malaria	3.27e-05	0.00046	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.27e-05	0.000458	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—CD36—malaria	3.24e-05	0.000455	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—IL1B—malaria	3.22e-05	0.000452	CbGpPWpGaD
Thalidomide—NFKB1—Myometrial Relaxation and Contraction Pathways—IL6—malaria	3.22e-05	0.000452	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—IL2—malaria	3.21e-05	0.00045	CbGpPWpGaD
Thalidomide—NFKB1—SIDS Susceptibility Pathways—IL6—malaria	3.2e-05	0.000449	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—HLA-B—malaria	3.17e-05	0.000445	CbGpPWpGaD
Thalidomide—FGFR2—Downstream signaling of activated FGFR—IL6—malaria	3.15e-05	0.000442	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CD36—malaria	3.11e-05	0.000437	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by ERBB4—IL6—malaria	3.1e-05	0.000435	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—CRP—malaria	3.08e-05	0.000432	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—SLC4A1—malaria	3.07e-05	0.000432	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—IL6—malaria	3.05e-05	0.000428	CbGpPWpGaD
Thalidomide—PTGS1—Selenium Micronutrient Network—IL6—malaria	3e-05	0.000422	CbGpPWpGaD
Thalidomide—FGFR2—Downstream signal transduction—IL6—malaria	2.96e-05	0.000416	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—TNF—malaria	2.96e-05	0.000415	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—TLR4—malaria	2.95e-05	0.000414	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by FGFR—IL6—malaria	2.95e-05	0.000414	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—CD36—malaria	2.95e-05	0.000413	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by ERBB2—IL6—malaria	2.93e-05	0.000412	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—CRP—malaria	2.92e-05	0.00041	CbGpPWpGaD
Thalidomide—FGFR2—DAP12 signaling—IL6—malaria	2.92e-05	0.00041	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	2.92e-05	0.000409	CbGpPWpGaD
Thalidomide—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—malaria	2.89e-05	0.000406	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—DECR1—malaria	2.89e-05	0.000406	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—DHODH—malaria	2.87e-05	0.000403	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.82e-05	0.000396	CbGpPWpGaD
Thalidomide—TNF—Adipogenesis—IL6—malaria	2.82e-05	0.000396	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	2.81e-05	0.000394	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	2.81e-05	0.000394	CbGpPWpGaD
Thalidomide—FGFR2—Disease—DHFR—malaria	2.8e-05	0.000394	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—TLR4—malaria	2.8e-05	0.000393	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TLR9—malaria	2.79e-05	0.000392	CbGpPWpGaD
Thalidomide—NFKB1—Cellular Senescence—IL6—malaria	2.78e-05	0.00039	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by FGFR in disease—IL6—malaria	2.75e-05	0.000385	CbGpPWpGaD
Thalidomide—FGFR2—DAP12 interactions—IL6—malaria	2.75e-05	0.000385	CbGpPWpGaD
Thalidomide—FGFR2—Fc epsilon receptor (FCERI) signaling—IL6—malaria	2.75e-05	0.000385	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by EGFR—IL6—malaria	2.72e-05	0.000382	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—ICAM1—malaria	2.72e-05	0.000381	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—DHODH—malaria	2.7e-05	0.000379	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by EGFR in Cancer—IL6—malaria	2.7e-05	0.000379	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—DHODH—malaria	2.7e-05	0.000379	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by PDGF—IL6—malaria	2.68e-05	0.000377	CbGpPWpGaD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL6—malaria	2.67e-05	0.000376	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TLR9—malaria	2.65e-05	0.000372	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—HBB—malaria	2.61e-05	0.000367	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.59e-05	0.000364	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—ICAM1—malaria	2.58e-05	0.000362	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—DHODH—malaria	2.55e-05	0.000358	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—KDR—malaria	2.55e-05	0.000357	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.51e-05	0.000352	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—SLC4A1—malaria	2.44e-05	0.000343	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—IL6—malaria	2.44e-05	0.000342	CbGpPWpGaD
Thalidomide—FGFR2—NGF signalling via TRKA from the plasma membrane—IL6—malaria	2.43e-05	0.000341	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—IL6—malaria	2.38e-05	0.000335	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—TNF—malaria	2.34e-05	0.000328	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PKLR—malaria	2.33e-05	0.000327	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.3e-05	0.000323	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—SLC4A1—malaria	2.3e-05	0.000323	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—DECR1—malaria	2.29e-05	0.000322	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—SLC4A1—malaria	2.29e-05	0.000322	CbGpPWpGaD
Thalidomide—PTGS2—Disease—PKLR—malaria	2.21e-05	0.00031	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—SLC4A1—malaria	2.17e-05	0.000304	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—DECR1—malaria	2.16e-05	0.000303	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—DECR1—malaria	2.16e-05	0.000303	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL18—malaria	2.14e-05	0.0003	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD40LG—malaria	2.13e-05	0.000299	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD8A—malaria	2.11e-05	0.000296	CbGpPWpGaD
Thalidomide—NFKB1—Cellular responses to stress—IL6—malaria	2.1e-05	0.000295	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—DHODH—malaria	2.08e-05	0.000293	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—CD4—malaria	2.08e-05	0.000292	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—G6PD—malaria	2.08e-05	0.000292	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—HBB—malaria	2.08e-05	0.000291	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.05e-05	0.000288	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—CD36—malaria	2.05e-05	0.000288	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—DECR1—malaria	2.04e-05	0.000286	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL18—malaria	2.03e-05	0.000285	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—HLA-B—malaria	2.03e-05	0.000285	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD40LG—malaria	2.02e-05	0.000284	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IL6—malaria	2e-05	0.000281	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD8A—malaria	2e-05	0.000281	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CD4—malaria	2e-05	0.00028	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD36—malaria	1.99e-05	0.000279	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—CD4—malaria	1.97e-05	0.000277	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by NGF—IL6—malaria	1.97e-05	0.000277	CbGpPWpGaD
Thalidomide—PTGS2—Disease—G6PD—malaria	1.97e-05	0.000276	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—HBB—malaria	1.95e-05	0.000274	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—HBB—malaria	1.95e-05	0.000274	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—HLA-B—malaria	1.92e-05	0.00027	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—DHODH—malaria	1.9e-05	0.000267	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CD4—malaria	1.89e-05	0.000266	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD36—malaria	1.89e-05	0.000265	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—IL6—malaria	1.89e-05	0.000265	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.88e-05	0.000264	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by NGF—IL6—malaria	1.87e-05	0.000263	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.87e-05	0.000262	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PKLR—malaria	1.85e-05	0.00026	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—HBB—malaria	1.84e-05	0.000259	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CRP—malaria	1.79e-05	0.000252	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—SLC4A1—malaria	1.77e-05	0.000249	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PKLR—malaria	1.74e-05	0.000244	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PKLR—malaria	1.74e-05	0.000244	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—TLR4—malaria	1.72e-05	0.000241	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.72e-05	0.000241	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CRP—malaria	1.7e-05	0.000239	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—DECR1—malaria	1.67e-05	0.000234	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—G6PD—malaria	1.65e-05	0.000231	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—ICAM1—malaria	1.65e-05	0.000231	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PKLR—malaria	1.64e-05	0.00023	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—TLR4—malaria	1.63e-05	0.000229	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	1.63e-05	0.000228	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—DHODH—malaria	1.62e-05	0.000228	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—SLC4A1—malaria	1.62e-05	0.000227	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.6e-05	0.000224	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.59e-05	0.000223	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—HPGDS—malaria	1.58e-05	0.000222	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—TNF—malaria	1.58e-05	0.000221	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—ICAM1—malaria	1.56e-05	0.000219	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—G6PD—malaria	1.55e-05	0.000218	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—G6PD—malaria	1.55e-05	0.000217	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—DECR1—malaria	1.52e-05	0.000213	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—HBB—malaria	1.51e-05	0.000212	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—DHFR—malaria	1.47e-05	0.000206	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.47e-05	0.000206	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—G6PD—malaria	1.46e-05	0.000205	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—SCARB1—malaria	1.45e-05	0.000204	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—CD36—malaria	1.44e-05	0.000203	CbGpPWpGaD
Thalidomide—FGFR2—Disease—NOS2—malaria	1.43e-05	0.000201	CbGpPWpGaD
Thalidomide—PTGS2—Disease—DHFR—malaria	1.39e-05	0.000196	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—SLC4A1—malaria	1.38e-05	0.000194	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—HBB—malaria	1.37e-05	0.000193	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PKLR—malaria	1.34e-05	0.000189	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—DECR1—malaria	1.3e-05	0.000182	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—IL6—malaria	1.27e-05	0.000179	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—HPGDS—malaria	1.26e-05	0.000177	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IFNG—malaria	1.25e-05	0.000176	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PKLR—malaria	1.22e-05	0.000172	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD4—malaria	1.21e-05	0.00017	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—G6PD—malaria	1.2e-05	0.000168	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IFNG—malaria	1.19e-05	0.000167	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—HPGDS—malaria	1.18e-05	0.000166	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—malaria	1.18e-05	0.000166	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—HPGDS—malaria	1.18e-05	0.000166	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—HBB—malaria	1.17e-05	0.000165	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—DHFR—malaria	1.17e-05	0.000164	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—SCARB1—malaria	1.15e-05	0.000162	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD4—malaria	1.15e-05	0.000161	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—IL6—malaria	1.12e-05	0.000158	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL1B—malaria	1.12e-05	0.000157	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—HPGDS—malaria	1.12e-05	0.000157	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL2—malaria	1.11e-05	0.000156	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—KDR—malaria	1.11e-05	0.000156	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—DHFR—malaria	1.1e-05	0.000154	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—DHFR—malaria	1.1e-05	0.000154	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—G6PD—malaria	1.09e-05	0.000153	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—SCARB1—malaria	1.09e-05	0.000153	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—SCARB1—malaria	1.08e-05	0.000152	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.08e-05	0.000151	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—IL6—malaria	1.07e-05	0.00015	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL1B—malaria	1.06e-05	0.000149	CbGpPWpGaD
Thalidomide—FGFR2—Disease—CD4—malaria	1.06e-05	0.000149	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL2—malaria	1.06e-05	0.000148	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—KDR—malaria	1.05e-05	0.000148	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PKLR—malaria	1.05e-05	0.000147	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—DHFR—malaria	1.04e-05	0.000145	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—SCARB1—malaria	1.02e-05	0.000144	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—IL6—malaria	9.7e-06	0.000136	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—G6PD—malaria	9.33e-06	0.000131	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	9.21e-06	0.000129	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—HPGDS—malaria	9.13e-06	0.000128	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—CD36—malaria	9.13e-06	0.000128	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—DHFR—malaria	8.47e-06	0.000119	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—SCARB1—malaria	8.38e-06	0.000118	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—HPGDS—malaria	8.33e-06	0.000117	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—DHFR—malaria	7.72e-06	0.000108	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—SCARB1—malaria	7.64e-06	0.000107	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—CD36—malaria	7.24e-06	0.000102	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL2—malaria	7.2e-06	0.000101	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—HPGDS—malaria	7.12e-06	9.99e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—NOS2—malaria	7.11e-06	9.98e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL2—malaria	6.83e-06	9.59e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—CD36—malaria	6.82e-06	9.57e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—CD36—malaria	6.81e-06	9.55e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—DHFR—malaria	6.6e-06	9.27e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL6—malaria	6.55e-06	9.19e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—SCARB1—malaria	6.53e-06	9.17e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—CD36—malaria	6.43e-06	9.03e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL6—malaria	6.21e-06	8.72e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—IL6—malaria	5.74e-06	8.05e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CD4—malaria	5.27e-06	7.4e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—CD36—malaria	5.26e-06	7.39e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—CD36—malaria	4.8e-06	6.74e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL6—malaria	4.23e-06	5.94e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—CD36—malaria	4.1e-06	5.76e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL6—malaria	4.02e-06	5.64e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—IL6—malaria	2.85e-06	4e-05	CbGpPWpGaD
